{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "EGRX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents at beginning of period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 114657000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 53821000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 5118000
            },
            {
                "label": "Total Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 15101000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 188697000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 6820000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 23322000
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 39743000
            },
            {
                "label": "Deferred tax asset, net",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 11354000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 124000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 270060000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 11981000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 15391000
            },
            {
                "label": "Current portion of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationLiabilityCurrent",
                "unit": "usd",
                "value": 15055000
            },
            {
                "label": "Current portion of long-term debt",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 4875000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 47302000
            },
            {
                "label": "Contingent consideration, less current portion",
                "concept": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
                "unit": "usd",
                "value": 709000
            },
            {
                "label": "Long-term debt, less current portion",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 42905000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, 1,500,000 shares authorized and no shares issued or outstanding as of December 31, 2017 and 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, $0.001 par value; 50,000,000 shares authorized; 16,089,439 and 15,890,862 issued as of December 31, 2017 and 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 16000
            },
            {
                "label": "Additional paid in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 233639000
            },
            {
                "label": "Retained earnings (Accumulated deficit)",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 26284000
            },
            {
                "label": "Value of common stock repurchased",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 80795000
            },
            {
                "label": "Stockholders' equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 179144000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 270060000
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 51943000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": 17289000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 932000
            },
            {
                "label": "Amortization expense",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 2815000
            },
            {
                "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 15429000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": -7377000
            },
            {
                "label": "Amortization of debt issuance cost",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 222000
            },
            {
                "label": "Gain on sale of diclofenac-misoprostol",
                "concept": "GainLossOnDispositionOfAssets1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Asset impairment charge",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 7235000
            },
            {
                "label": "Loss on disposal of fixed assets",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Increase in accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 11627000
            },
            {
                "label": "(Increase) decrease in inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 2379000
            },
            {
                "label": "Decrease (increase) in prepaid expenses and other assets",
                "concept": "egrx:IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal",
                "unit": "usd",
                "value": -1993000
            },
            {
                "label": "(Decrease) increase in accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -8460000
            },
            {
                "label": "Decrease in deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "(Decrease) increase in accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": -9096000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 58919000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 4436000
            },
            {
                "label": "Purchase of short term investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Maturities of short term investments",
                "concept": "ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Payment for business acquisition",
                "concept": "PaymentsToAcquireBusinessesGross",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Payment for Ryanodex intangible asset",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 750000
            },
            {
                "label": "Purchase of Eagle Biologics, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sale of diclofenac-misoprostol",
                "concept": "ProceedsFromSaleOfProductiveAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -5186000
            },
            {
                "label": "Repurchases of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 43792000
            },
            {
                "label": "Payment of contingent consideration",
                "concept": "egrx:PaymentsforContingentConsideration",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceed from debt issuance",
                "concept": "ProceedsFromIssuanceOfDebt",
                "unit": "usd",
                "value": 50000000
            },
            {
                "label": "Payment of debt principal",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 1250000
            },
            {
                "label": "Payment of debt financing costs",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 1192000
            },
            {
                "label": "Proceeds from common stock option exercise",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 4338000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 8104000
            },
            {
                "label": "Net increase (decrease) in cash",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 61837000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 10542000
            },
            {
                "label": "Interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 651000
            },
            {
                "label": "Landlord contribution to leasehold improvements recorded as deferred rent",
                "concept": "egrx:NoncashOperatingActivityDeferredRent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Value of common stock issued for the Eagle Biologics acquisition",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Contingent consideration - business acquisitions",
                "concept": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
                "unit": "usd",
                "value": 0
            }
        ],
        "ic": [
            {
                "label": "Product sales",
                "concept": "SalesRevenueGoodsNet",
                "unit": "usd",
                "value": 45327000
            },
            {
                "label": "Royalty revenue",
                "concept": "RoyaltyRevenue",
                "unit": "usd",
                "value": 153880000
            },
            {
                "label": "Other revenue",
                "concept": "OtherSalesRevenueNet",
                "unit": "usd",
                "value": 37500000
            },
            {
                "label": "Revenue",
                "concept": "SalesRevenueNet",
                "unit": "usd",
                "value": 236707000
            },
            {
                "label": "Cost of product sales",
                "concept": "CostOfGoodsSold",
                "unit": "usd",
                "value": 33714000
            },
            {
                "label": "Cost of royalty revenue",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 23472000
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 32607000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 71416000
            },
            {
                "label": "Gain on sale of diclofenac-misoprostol",
                "concept": "GainLossOnDispositionOfAssets1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Asset impairment charge",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 7235000
            },
            {
                "label": "Change in fair value of contingent consideration",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": -7377000
            },
            {
                "label": "Legal settlement",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 1650000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 162717000
            },
            {
                "label": "Income (Loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 73990000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 91000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1136000
            },
            {
                "label": "Total other (expense) income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1045000
            },
            {
                "label": "Income before income tax (provision) benefit",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": 72945000
            },
            {
                "label": "Income tax (provision) benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 21002000
            },
            {
                "label": "Net income",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 51943000
            },
            {
                "label": "Income (loss) per share attributable to common stockholders- basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 3.44
            },
            {
                "label": "Income (loss) per share attributable to common stockholders- diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 3.27
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 15102890
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 15908211
            }
        ]
    }
}